Risk of diabetes in a real-world setting among patients initiating antihypertensive therapy with valsartan or amlodipine.
Weycker, D
Risk of diabetes in a real-world setting among patients initiating antihypertensive therapy with valsartan or amlodipine. [electronic resource] - Journal of human hypertension May 2007 - 374-80 p. digital
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
0950-9240
10.1038/sj.jhh.1002159 doi
Adult
Aged
Amlodipine--therapeutic use
Antihypertensive Agents--adverse effects
Databases, Factual
Diabetes Mellitus--chemically induced
Diabetes Mellitus, Type 2--chemically induced
Female
Follow-Up Studies
Humans
Hypertension--drug therapy
Male
Middle Aged
Multivariate Analysis
Retrospective Studies
Risk Assessment
Risk Factors
Risk Reduction Behavior
Tetrazoles--therapeutic use
Time Factors
Treatment Outcome
United States--epidemiology
Valine--analogs & derivatives
Valsartan
Risk of diabetes in a real-world setting among patients initiating antihypertensive therapy with valsartan or amlodipine. [electronic resource] - Journal of human hypertension May 2007 - 374-80 p. digital
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
0950-9240
10.1038/sj.jhh.1002159 doi
Adult
Aged
Amlodipine--therapeutic use
Antihypertensive Agents--adverse effects
Databases, Factual
Diabetes Mellitus--chemically induced
Diabetes Mellitus, Type 2--chemically induced
Female
Follow-Up Studies
Humans
Hypertension--drug therapy
Male
Middle Aged
Multivariate Analysis
Retrospective Studies
Risk Assessment
Risk Factors
Risk Reduction Behavior
Tetrazoles--therapeutic use
Time Factors
Treatment Outcome
United States--epidemiology
Valine--analogs & derivatives
Valsartan